We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency

By LabMedica International staff writers
Posted on 26 Feb 2026

Urine testing is a critical, non-invasive diagnostic tool used to detect conditions such as pregnancy, urinary tract infections, metabolic disorders, cancer, and kidney disease. More...

However, contaminated or improperly collected urine samples can lead to incorrect results, delayed care, or inappropriate treatment. One study found that nearly 44 percent of patients with contaminated urine cultures received unnecessary antibiotic therapy, highlighting the clinical impact of preanalytical errors. Now, a newly introduced three-tube urine collection system aims to preserve specimen integrity, reduce contamination risk,s and enable broader testing from a single sample, minimizing repeat collections and improving workflow efficiency.

BD (Becton, Dickinson and Company) (Franklin Lakes, NJ, USA) has launched the BD Vacutainer Urine Complete Cup Kit that preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care. Designed as a closed-system, the three-tube collection solution expands testing capabilities from one urine specimen while supporting automated laboratory workflows.

The kit includes a sterile urine cup with an integrated transfer device, a tube for culture and sensitivity testing to detect bacteria or fungi, a tube for urinalysis to assess general health and disease markers, a discard tube without additives, and a castile wipe for patient preparation. The innovative third-tube design allows clinicians to perform additional testing without manually transferring urine or collecting a new specimen.

The kit supports broader diagnostic evaluation while reducing healthcare worker exposure and lowering contamination risks associated with manual transfers. Enabling multiple tests from a single collection, it helps decrease the likelihood of repeat patient sampling and associated workflow disruptions. Closed-system solutions such as those in the BD Vacutainer Urine Collection portfolio are intended to minimize preanalytical errors and improve the reliability of laboratory results. The system is available in the United States with both Hemogard and conventional stoppered tubes and is compatible with a wide range of diagnostic equipment.

By streamlining specimen management, the collection kit is designed to enhance diagnostic accuracy and support timely treatment decisions. It can be integrated into existing laboratory processes and automated workflows, helping healthcare facilities improve efficiency across the urine specimen management continuum. The expanded testing capability from a single specimen can reduce contamination-related errors and unnecessary antibiotic use, contributing to safer and more effective patient care.

"Improving diagnostic accuracy starts long before a sample reaches the lab," said Bridget Bagnato, worldwide president of Specimen Management at BD. "This kit reflects the innovation we deliver to help clinicians determine effective treatment options through more accurate diagnosis and ultimately support better patient management."

Related Links:
BD 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.